1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 35
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Breakdown of primary sources 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION,
AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC (2021) 37
2.3 MARKET GROWTH RATE PROJECTIONS 39
FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTION 39
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 7 DATA TRIANGULATION METHODOLOGY 40
2.5 MARKET SHARE ESTIMATION 41
2.6 ASSUMPTIONS FOR THE STUDY 41
2.7 LIMITATIONS FOR RESEARCH 41
3 EXECUTIVE SUMMARY 42
FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 42
FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2022 VS. 2027 (USD MILLION) 43
FIGURE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 44
FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 45
FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 46
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 47
4 PREMIUM INSIGHTS 48
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW 48
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH 48
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT (2021) 49
FIGURE 15 KITS TO DOMINATE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2021 49
4.3 GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 50
FIGURE 16 JAPAN TO WITNESS HIGHEST MARKET GROWTH RATE FROM 2022 TO 2027 50
4.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 51
FIGURE 17 NORTH AMERICA TO DOMINATE MARKET IN 2027 51
4.5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEVELOPED VS. DEVELOPING MARKETS 52
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE
IN FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 MARKET DYNAMICS 53
FIGURE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 53
5.1.1 DRIVERS 54
5.1.1.1 Increasing R&D activities 54
5.1.1.2 Technological advancements and increasing automation 55
5.1.2 RESTRAINTS 55
5.1.2.1 High cost of automated instruments 55
5.1.3 OPPORTUNITIES 55
5.1.3.1 High scope of growth in emerging economies 55
5.1.3.2 Improving regulatory and reimbursement scenario 56
5.1.3.3 Molecular diagnostics and personalized medicine 56
5.1.4 TRENDS 57
5.1.4.1 Increase in government funding 57
5.2 COVID-19 IMPACT ON THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 57
5.3 PORTER’S FIVE FORCES ANALYSIS 58
TABLE 1 PORTER’S FIVE FORCES ANALYSIS 58
5.3.1 THREAT FROM NEW ENTRANTS 59
5.3.2 THREAT FROM SUBSTITUTES 59
5.3.3 BARGAINING POWER OF SUPPLIERS 59
5.3.4 BARGAINING POWER OF BUYERS 59
5.3.5 DEGREE OF COMPETITION 59
5.4 TECHNOLOGY ANALYSIS 59
5.5 SUPPLY CHAIN ANALYSIS 61
FIGURE 20 SUPPLY CHAIN ANALYSIS: NUCLEIC ACID ISOLATION AND
PURIFICATION MARKET 61
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 62
6.1 INTRODUCTION 63
TABLE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2019–2021 (USD MILLION) 63
TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2022–2027 (USD MILLION) 64
6.2 PLASMID DNA ISOLATION AND PURIFICATION 64
6.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 64
TABLE 4 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 65
TABLE 5 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 66
6.3 TOTAL RNA ISOLATION AND PURIFICATION 66
6.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO
REGISTER STEADY GROWTH 66
TABLE 6 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 67
TABLE 7 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 67
6.4 GENOMIC DNA ISOLATION AND PURIFICATION 68
6.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS 68
TABLE 8 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 68
TABLE 9 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 69
6.5 MESSENGER RNA ISOLATION AND PURIFICATION 69
6.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS 69
TABLE 10 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION) 70
TABLE 11 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION) 70
6.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 71
6.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 71
TABLE 12 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY REGION, 2019–2021 (USD MILLION) 71
TABLE 13 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY REGION, 2022–2027 (USD MILLION) 72
6.7 MICRORNA ISOLATION AND PURIFICATION 72
6.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF
RNA MOLECULES FROM SAMPLES 72
TABLE 14 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2019–2021 (USD MILLION) 73
TABLE 15 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,
2022–2027 (USD MILLION) 73
6.8 PCR CLEANUP 74
6.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD 74
TABLE 16 PCR CLEANUP MARKET, BY REGION, 2019–2021 (USD MILLION) 74
TABLE 17 PCR CLEANUP MARKET, BY REGION, 2022–2027 (USD MILLION) 74
6.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES 75
TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,
BY REGION, 2019–2021 (USD MILLION) 75
TABLE 19 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,
BY REGION, 2022–2027 (USD MILLION) 76
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 77
7.1 INTRODUCTION 78
TABLE 20 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2019–2021 (USD MILLION) 78
TABLE 21 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,
2022–2027 (USD MILLION) 78
7.2 COLUMN-BASED ISOLATION AND PURIFICATION 79
7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION IS LARGEST SEGMENT
OF MARKET 79
TABLE 22 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION) 79
TABLE 23 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION) 80
7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 80
7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT
TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 80
TABLE 24 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,
BY REGION, 2019–2021 (USD MILLION) 81
TABLE 25 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,
BY REGION, 2022–2027 (USD MILLION) 81
7.4 REAGENT-BASED ISOLATION AND PURIFICATION 81
7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH BETWEEN 2022 AND 2027 81
TABLE 26 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION) 82
TABLE 27 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION) 82
7.5 OTHER ISOLATION AND PURIFICATION METHODS 83
TABLE 28 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2019–2025 (USD MILLION) 83
TABLE 29 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2022–2027 (USD MILLION) 83
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 84
8.1 INTRODUCTION 85
TABLE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2019–2021 (USD MILLION) 85
TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,
2022–2027 (USD MILLION) 85
8.2 KITS 86
8.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2021 86
TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2019–2021 (USD MILLION) 86
TABLE 33 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2022–2027 (USD MILLION) 87
8.3 REAGENTS 87
8.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING
THE FORECAST PERIOD 87
TABLE 34 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,
BY REGION, 2019–2021 (USD MILLION) 88
TABLE 35 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,
BY REGION, 2022–2027 (USD MILLION) 88
8.4 INSTRUMENTS 89
8.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS 89
TABLE 36 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,
BY REGION, 2019–2021 (USD MILLION) 89
TABLE 37 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,
BY REGION, 2022–2027 (USD MILLION) 90
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 91
9.1 INTRODUCTION 92
TABLE 38 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019–2021 (USD MILLION) 92
TABLE 39 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 92
9.2 DIAGNOSTICS 93
9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET 93
TABLE 40 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2021 (USD MILLION) 93
TABLE 41 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2027 (USD MILLION) 94
9.3 DRUG DISCOVERY & DEVELOPMENT 94
9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS
THERAPEUTIC AREAS 94
TABLE 42 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2021 (USD MILLION) 95
TABLE 43 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2027 (USD MILLION) 95
9.4 PERSONALIZED MEDICINE 96
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE SEGMENT GROWTH 96
TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2019–2021 (USD MILLION) 96
TABLE 45 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2027 (USD MILLION) 97
9.5 AGRICULTURE & ANIMAL RESEARCH 97
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH 97
TABLE 46 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2019–2021 (USD MILLION) 98
TABLE 47 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2027 (USD MILLION) 98
9.6 OTHER APPLICATIONS 99
TABLE 48 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2021 (USD MILLION) 99
TABLE 49 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2027 (USD MILLION) 100
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 101
10.1 INTRODUCTION 102
TABLE 50 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2019–2021 (USD MILLION) 102
TABLE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2022–2027 (USD MILLION) 102
10.2 HOSPITALS & DIAGNOSTIC CENTERS 103
10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH 103
TABLE 52 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2019–2021 (USD MILLION) 104
TABLE 53 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2027 (USD MILLION) 104
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 104
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS 104
TABLE 54 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2021 (USD MILLION) 105
TABLE 55 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022–2027 (USD MILLION) 106
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 106
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH 106
TABLE 56 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2019–2021 (USD MILLION) 107
TABLE 57 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2022–2027 (USD MILLION) 107
10.5 CONTRACT RESEARCH ORGANIZATIONS 107
10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING FORECAST PERIOD 107
TABLE 58 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2021 (USD MILLION) 108
TABLE 59 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2027 (USD MILLION) 108
10.6 OTHER END USERS 108
TABLE 60 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2019–2021 (USD MILLION) 109
TABLE 61 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR
OTHER END USERS, BY REGION, 2022–2027 (USD MILLION) 109
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 110
11.1 INTRODUCTION 111
TABLE 62 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION,
2020–2027 (USD MILLION) 111
11.2 NORTH AMERICA 111
FIGURE 21 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 112
TABLE 63 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 64 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 65 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 113
TABLE 66 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 67 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 114
TABLE 68 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
11.2.1 US 115
11.2.1.1 Government and private funding to support market growth 115
TABLE 69 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116
TABLE 70 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 116
TABLE 71 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
TABLE 72 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 73 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 118
11.2.2 CANADA 118
11.2.2.1 Growing investments in genomics to boost market demand 118
TABLE 74 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 75 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 119
TABLE 76 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 77 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 120
TABLE 78 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 121
11.3 EUROPE 121
TABLE 79 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 80 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 81 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 122
TABLE 82 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 83 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 84 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 124
11.3.1 GERMANY 124
11.3.1.1 Germany to dominate market in Europe 124
TABLE 85 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027 125
TABLE 86 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 87 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 126
TABLE 88 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 89 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 127
TABLE 90 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 127
11.3.2 UK 127
11.3.2.1 Government support for research through investments, funds, and grants to support market growth 127
TABLE 91 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 92 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 128
TABLE 93 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE,
2020–2027 (USD MILLION) 129
TABLE 94 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 95 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 130
11.3.3 FRANCE 130
11.3.3.1 High cancer burden to drive market growth 130
TABLE 96 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 97 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 131
TABLE 98 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 99 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 100 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 133
11.3.4 REST OF EUROPE 133
TABLE 101 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 102 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 134
11.4 ASIA PACIFIC 135
FIGURE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 135
TABLE 103 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 104 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 136
TABLE 105 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 136
TABLE 106 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 107 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 137
TABLE 108 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 138
11.4.1 CHINA 138
11.4.1.1 China is expected to register the highest growth in the nucleic acid isolation and purification market in the APAC 138
TABLE 109 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139
TABLE 110 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 139
TABLE 111 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 112 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 113 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 141
11.4.2 JAPAN 141
11.4.2.1 Various conferences & workshops are organized to explore various NAIP applications; a key factor driving market growth 141
TABLE 114 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142
TABLE 115 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 142
TABLE 116 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 117 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 118 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 144
11.4.3 INDIA 144
11.4.3.1 Focused initiatives in the pharmaceutical & biotechnology industries to drive the market growth for NAIP in India 144
TABLE 119 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 144
TABLE 120 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 145
TABLE 121 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 122 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 123 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 146
11.4.4 REST OF ASIA PACIFIC (ROAPAC) 147
TABLE 124 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 147
TABLE 125 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 148
TABLE 126 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 127 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 149
TABLE 128 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 149
11.5 REST OF THE WORLD 150
TABLE 129 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 130 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 131 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 150
TABLE 132 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 133 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 151
TABLE 134 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 152
11.5.1 LATIN AMERICA 152
11.5.1.1 Increasing cancer cases to drive the demand for cancer diagnostic tests and, in turn, drive market growth for NAIP 152
TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 136 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY METHOD, 2020–2027 (USD MILLION) 153
TABLE 137 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 138 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 139 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 155
11.5.2 MIDDLE EAST & AFRICA 155
11.5.2.1 Lack of research infrastructure to restrict the growth of the NAIP market in this region 155
TABLE 140 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156
TABLE 141 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION) 156
TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 143 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157
TABLE 144 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION) 158
TABLE 145 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 146 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 159
TABLE 147 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,
BY END USER, 2020–2027 (USD MILLION) 159
12 COMPETITIVE LANDSCAPE 160
12.1 OVERVIEW 160
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 160
FIGURE 23 KEY DEVELOPMENTS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019-2022 160
12.3 MARKET SHARE ANALYSIS 161
FIGURE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE,
BY KEY PLAYER, 2021 161
TABLE 148 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET:
DEGREE OF COMPETITION 161
12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 162
FIGURE 25 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019–2021 162
12.5 COMPANY EVALUATION QUADRANT 163
12.5.1 STARS 163
12.5.2 EMERGING LEADERS 163
12.5.3 PERVASIVE PLAYERS 163
12.5.4 PARTICIPANTS 163
FIGURE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT, 2021 164
12.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 165
12.6.1 PROGRESSIVE COMPANIES 165
12.6.2 STARTING BLOCKS 165
12.6.3 RESPONSIVE COMPANIES 165
12.6.4 DYNAMIC COMPANIES 165
FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 166
12.7 COMPANY FOOTPRINT ANALYSIS 167
12.7.1 COMPANY PRODUCT FOOTPRINT 167
TABLE 149 COMPANY PRODUCT FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021) 167
12.8 COMPANY REGIONAL FOOTPRINT 168
TABLE 150 COMPANY REGIONAL FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021) 168
12.9 COMPETITIVE SCENARIO 169
TABLE 151 PRODUCT LAUNCHES 169
TABLE 152 DEALS 169
TABLE 153 OTHER DEVELOPMENTS 170
13 COMPANY PROFILES 171
13.1 MAJOR PLAYERS 171
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 THERMO FISHER SCIENTIFIC, INC. 171
TABLE 154 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 171
FIGURE 28 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 172
13.1.2 MERCK KGAA 176
TABLE 155 MERCK KGAA: BUSINESS OVERVIEW 176
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2021) 177
13.1.3 QIAGEN 182
TABLE 156 QIAGEN: BUSINESS OVERVIEW 182
FIGURE 30 QIAGEN: COMPANY SNAPSHOT (2021) 183
13.1.4 F. HOFFMANN-LA ROCHE AG 186
TABLE 157 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 186
FIGURE 31 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 187
13.1.5 GENERAL ELECTRIC COMPANY 191
TABLE 158 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW 191
FIGURE 32 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021) 192
13.1.6 PROMEGA CORPORATION 194
TABLE 159 PROMEGA CORPORATION: BUSINESS OVERVIEW 194
13.1.7 AGILENT TECHNOLOGIES, INC. 197
TABLE 160 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 197
FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 198
13.1.8 DANAHER CORPORATION 201
TABLE 161 DANAHER CORPORATION: BUSINESS OVERVIEW 201
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 202
13.1.9 BIO-RAD LABORATORIES, INC. 205
TABLE 162 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 205
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 206
13.1.10 ILLUMINA, INC. 208
TABLE 163 ILLUMINA, INC.: BUSINESS OVERVIEW 208
FIGURE 36 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 209
13.1.11 TAKARA BIO, INC. 211
TABLE 164 TAKARA BIO, INC.: BUSINESS OVERVIEW 211
13.1.12 NEW ENGLAND BIOLABS 215
TABLE 165 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 215
13.1.13 OMEGA BIO-TEK, INC. 217
TABLE 166 OMEGA BIO-TEK, INC.: BUSINESS OVERVIEW 217
13.1.14 NORGEN BIOTEK 219
TABLE 167 NORGEN BIOTEK: BUSINESS OVERVIEW 219
13.1.15 ZYMO RESEARCH 221
TABLE 168 ZYMO RESEARCH: BUSINESS OVERVIEW 221
13.2 OTHER COMPANIES 224
13.2.1 GENAXXON BIOSCIENCE GMBH 224
TABLE 169 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW 224
13.2.2 3D BLACKBIO BIOTECH INDIA LTD. 225
TABLE 170 3D BLACKBIO BIOTECH INDIA LTD.: COMPANY OVERVIEW 225
13.2.3 INVITEK MOLECULAR GMBH 226
TABLE 171 INVITEK MOLECULAR GMBH: COMPANY OVERVIEW 226
13.2.4 BIOVISION 228
TABLE 172 BIOVISION: COMPANY OVERVIEW 228
13.2.5 ANALYTIK JENA AG 229
TABLE 173 ANALYTIK JENA AG: COMPANY OVERVIEW 229
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 230
14.1 DISCUSSION GUIDE 230
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
14.3 AVAILABLE CUSTOMIZATIONS 235
14.4 RELATED REPORTS 236
14.5 AUTHOR DETAILS 237
Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027核酸単離＆精製のグローバル市場予測（～2027）：キット、試薬、機器 |
◆タイトル：Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027
◆商品コード：BT2398-22
◆調査・発行会社：MarketsandMarkets
◆発行日：2022年6月17日
◆ページ数：230
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。
【レポートの概要】
◆商品コード：BT2398-22
◆調査・発行会社：MarketsandMarkets
◆発行日：2022年6月17日
◆ページ数：230
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
| Single User（1名様閲覧） | USD4,950 ⇒換算￥0 | 見積依頼/購入/質問フォーム |
| Multi User (Five User) | USD6,650 ⇒換算￥0 | 見積依頼/購入/質問フォーム |
| Corporate License (全社内共有可) | USD8,150 ⇒換算￥0 | 見積依頼/購入/質問フォーム |
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。
【レポートの概要】
| マーケッツアンドマーケッツ社は、世界の核酸単離＆精製市場規模が、2022年63億ドルから2027年92億ドルまで年平均7.9％成長すると予測しています。本調査資料では、核酸単離＆精製の世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（プラスミドDNA、トータルRNA、ゲノムDNA、メッセンジャーRNA、循環核酸）分析、方法別（カラム、磁気ビーズ、試薬、その他）分析、製品別（キット、試薬、機器）分析、用途別（診断、創薬・開発、個別化医療、農業＆動物研究、その他）分析、地域別分析、競争状況、企業情報などの内容をまとめております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の核酸単離＆精製市場規模：種類別（プラスミドDNA、トータルRNA、ゲノムDNA、メッセンジャーRNA、循環核酸） ・世界の核酸単離＆精製市場規模：方法別（カラム、磁気ビーズ、試薬、その他） ・世界の核酸単離＆精製市場規模：製品別（キット、試薬、機器） ・世界の核酸単離＆精製市場規模：用途別（診断、創薬・開発、個別化医療、農業＆動物研究、その他） ・世界の核酸単離＆精製市場規模：地域別 ・競争状況 ・企業情報 |
“The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period.”
The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.
As the world becomes more connected, collaboration and cooperation are needed to reduce the impact of future epidemics. To reduce the risk of future epidemics, increasing research is being conducted across the globe. For instance, the National Institutes of Health (US) invests USD 40 billion annually in health innovation and is expected to spend billions more on COVID- 19 research. Similarly, the UK government has decided to increase its R&D spending over the next three years to reach USD 28.82 billion (GBP 22 billion) by 2024–25. Countries in Asia, such as China and India, have also increased investments in their healthcare and pharmaceutical sectors.
“The instruments segment will grow at the highest rate during the forecast period.”
On the basis ofproduct, the nucleic acid isolation and purification market is segmented intokits, reagents, and instruments. In 2021, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.
“By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.”
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation andpurification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
“The market in the Asia Pacificis projected to witness the highest growth rate during the forecast period (2020–2027).”
North America accounted for the largest share of the nucleic acid isolation and purification market in 2021. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacificis projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1(29%), Tier 2(37%), and Tier 3(34%)
• By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals& Diagnostic Centers (30%), and Academic &Government Research Institutes (22%), and Other End Users (10%)
• By Designation: C-level(37%), Director-level(23%), and Managers(40%)
• By Region: North America(37%), Europe(30%), Asia Pacific(21%), and the RoW(12%)
QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GEHealthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
Research Coverage:
The report analyzes the nucleic acid isolation and purification market and aims at estimating themarket size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one, or a combination of the belowmentioned five strategies.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutionsacross regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.
【レポートの目次】
| ★調査レポート[核酸単離＆精製のグローバル市場予測（～2027）：キット、試薬、機器] ( Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027 / BT2398-22) 販売に関する免責事項 |
| [核酸単離＆精製のグローバル市場予測（～2027）：キット、試薬、機器] ( Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027 / BT2398-22) についてEメールでお問い合わせ |
◆H&Iグローバルリサーチ株式会社のお客様（例）◆
